Page last updated: 2024-08-22

gadolinium and Hyperphosphatemia

gadolinium has been researched along with Hyperphosphatemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Dencausse, A; Factor, C; Fretellier, N; Guerret, S; Idée, J; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Port, M; Poveda, N	1

Other Studies

1 other study(ies) available for gadolinium and Hyperphosphatemia

Article	Year
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide. British journal of pharmacology, 2012, Volume: 165, Issue:4b Topics: Animals; Contrast Media; Disease Models, Animal; Femur; Gadolinium; Gadolinium DTPA; Hyperphosphatemia; Liver; Male; Nephrogenic Fibrosing Dermopathy; Procollagen-Proline Dioxygenase; Rats; Rats, Wistar; Renal Insufficiency; Risk Factors; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1	2012

Article

Year

Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.

British journal of pharmacology, 2012, Volume: 165, Issue:4b

Topics: Animals; Contrast Media; Disease Models, Animal; Femur; Gadolinium; Gadolinium DTPA; Hyperphosphatemia; Liver; Male; Nephrogenic Fibrosing Dermopathy; Procollagen-Proline Dioxygenase; Rats; Rats, Wistar; Renal Insufficiency; Risk Factors; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1

2012